Faculty profile

Anita Villani

Back to faculty

Associate ProfessorDepartment of PaediatricsUniversity of Toronto

Anita Villani

Associate Professor

Department of Paediatrics

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
37 publications in the last five years, latest in 2026.
Senior (last) author on 5 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

2,575

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Prior therapy defines mutation profiles in childhood cancer at relapse.
Nature · 2026
The Patient-reported Genetic testing Utility InDEx: A novel measure of personal utility.
Genetics in medicine : official journal of the American College of Medical Genetics · 2026
Digital Health Tools Embedded in a Cancer Genetics Clinic: Observational Study.
JMIR formative research · 2026

All 60 publications

Latest funding

Towards patient-centred precision oncology care for children and youth: Understanding psychosocial impacts and experiences through patient and professional perspectives
CIHR · 2024 · Co-investigator
$1,013,626
Towards patient-centred precision oncology care for children and youth: Understanding value through patient and professional perspectives
CIHR · 2023 · Co-investigator
$100,000
Genome-wide Sequencing: Secondary Findings Impact Study (SF-Impact Study)
CIHR · 2022 · Co-investigator
$100,000

All 8 grants and awards

60 publications.

Prior therapy defines mutation profiles in childhood cancer at relapse.

Layeghifard M, Díaz-Gay M, Bergstrom EN, Mahendralingam MJ, Light N, Blay S, Nash JO, Anderson ND, Au JN, Davidson S, Ballester PL, Wen T, Daud SK, Edward LM, Ashiqul Islam SM, Khandekar A, Otlu B, Brunga L, Hammad R, Nassif S, Thacker NH, Feltham T, Fuentes-Bolanos NA, Wong-Erasmus M, Levine MF, Miller KE, Shukla NN, Kinnaman MD, Glodzik D, Portwine C, Millson S, Zorzi AP, Mikhail M, Fernandez CV, Wheaton L, Gundem G, Kung AL, Tabori U, Mayoh C, Papaemmanuil E, Cowley MJ, Malkin D, Villani A, Alexandrov LB, Shlien A

Nature20261 citationsOpen Access

DOI: 10.1038/s41586-026-10803-1 PMID: 42486975

The Patient-reported Genetic testing Utility InDEx: A novel measure of personal utility.

Poole E, Xiao B, Luca S, Assamad D, Abbott LS, Armstrong L, Boycott KM, Carroll JC, Chad L, De Bie I, Denburg A, Deyell RJ, Elliott AM, Goudie C, Laberge AM, Mucha BE, Peltekova IT, Quinlan B, Sawyer SL, Smith M, Villani A, Ungar WJ, Hayeems RZ, P-GUIDE Study Team

Genetics in medicine : official journal of the American College of Medical Genetics2026Open Access

DOI: 10.1016/j.gim.2026.102670 PMID: 42554147

Digital Health Tools Embedded in a Cancer Genetics Clinic: Observational Study.

Nagaraj S, Rabinowicz R, Goodday S, Brunga L, Korenblum C, Villani A, Kim R, Karlin E, Greer RW, Balaci H, Omran M, Goldenberg A, Malkin D, Friend S

JMIR formative research2026Open Access

DOI: 10.2196/74375 PMID: 41627862

Two cases of mosaic germline SVA insertions in SMARCB1: implications for rhabdoid tumour predisposition diagnosis.

Raiti L, Yuki KE, Cinq-Mars L, Higginbotham EJ, Navickiene V, Li Y, Wang Z, Thiruv B, Charlinski T, Gallinger B, Venier RE, Huang A, Denburg A, Chun K, Villani A

NPJ genomic medicine2026Senior authorOpen Access

DOI: 10.1038/s41525-026-00584-x PMID: 42248890

Understanding the impact of genomic secondary findings on clinical care and patient experience: a protocol for a prospective observational study

Assamad D, Hansen A, Fooks K, Luca S, Venkataramanan V, Hsue E, Shickh S, Yan J, Wu V, Badalato L

BMJ Open2026Open Access

DOI: 10.1136/bmjopen-2025-115821

Understanding the decision of parents to opt‐out of medically actionable secondary findings offered through genome sequencing

Hansen A, Luca S, Moran O, Babul‐Hirji R, Coe TB, Wilk K, Assamad D, Fooks K, Venkataramanan V, Shickh S

Journal of Genetic Counseling2026Open Access

DOI: 10.1002/jgc4.70218

High clinical utility of comprehensive multi-omic molecular profiling of rare and hard-to-diagnose pediatric tumors.

Sullivan AJ, Khuong-Quang DA, Villani A, Wong-Erasmus M, Trinder S, Lau LMS, Barahona P, Altekoester AK, Rumford M, Dias K, Mayoh C, Fuentes-Bolanos NA, Courtney EK, El-Kamand S, Cui L, Lin A, Davidson S, Yuki KE, Sanders N, Staunton J, Jessop S, Sriharan S, Alvaro F, Anazodo A, Bhatia K, Campbell M, Foresto S, Gottardo NG, Kirby M, Khaw SL, Manoharan N, McCowage G, Moore AS, Nicholls W, O'Connor M, Padhye B, Ryan AL, Super L, Wood PJ, Davies J, D'Arcy C, Gifford AJ, Rodriguez M, Tucker KM, Pinese M, Ekert PG, Haber M, Tyrrell V, Trahair TN, Marshall GM, Shlien A, Cowley MJ, Ziegler DS

medRxiv : the preprint server for health sciences2026Open Access

DOI: 10.64898/2026.07.25.26358936 PMID: 42619885

High clinical utility of comprehensive multi-omic molecular profiling of rare and hard-to-diagnose pediatric tumors.

Research square2026Open Access

DOI: 10.21203/rs.3.rs-10108527/v1 PMID: 42620518

Frequency and face validity of reported family history of cancer in first-degree relatives and genetic syndromes among children with cancer in Project:EveryChild: A report from the Children's Oncology Group.

Fuentes Bolanos NA, Lupo PJ, Tucker KM, Hawkins DS, Porter CC, Villani A, Spector LG

Cancer2026

DOI: 10.1002/cncr.70231 PMID: 41457435

Childhood cancer predisposition study: a prospective registry and biorepository protocol.

Perrino MR, MacFarland SP, Maese L, Vagher J, Kamihara J, Rednam S, Lupo PJ, Brodeur GM, Schiffman J, Diller L, Desrosiers-Battu L, Plon SE, Nichols KE, Volchenboum SL, Malkin D, Villani A, Porter CC

BMJ open2026

DOI: 10.1136/bmjopen-2026-120576 PMID: 42556843

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Anita Villani

Research

Latest papers

Latest funding

Prior therapy defines mutation profiles in childhood cancer at relapse.

The Patient-reported Genetic testing Utility InDEx: A novel measure of personal utility.

Digital Health Tools Embedded in a Cancer Genetics Clinic: Observational Study.

Two cases of mosaic germline SVA insertions in SMARCB1: implications for rhabdoid tumour predisposition diagnosis.

Understanding the impact of genomic secondary findings on clinical care and patient experience: a protocol for a prospective observational study

Understanding the decision of parents to opt‐out of medically actionable secondary findings offered through genome sequencing

High clinical utility of comprehensive multi-omic molecular profiling of rare and hard-to-diagnose pediatric tumors.

High clinical utility of comprehensive multi-omic molecular profiling of rare and hard-to-diagnose pediatric tumors.

Frequency and face validity of reported family history of cancer in first-degree relatives and genetic syndromes among children with cancer in Project:EveryChild: A report from the Children's Oncology Group.

Childhood cancer predisposition study: a prospective registry and biorepository protocol.

Frequent collaborators

David Malkin

Adam Shlien

Uri Tabori

Daniel Morgenstern

Mary-Louise Greer

Catherine Goudie

Johann Hitzler

Annie Huang

Cynthia Hawkins

Meredith Irwin

Trevor Pugh

Gino Somers

Avram Denburg

Mohamed Abdelhaleem

Mary Shago

Anna Goldenberg

Lauren Chad

Raymond Kim

Ronald Grant

William Foulkes

Wendy Ungar

Joerg Krueger

Angela Punnett

Rebecca Levy

Ahmed Naqvi